Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy. (Q42910001)
Jump to navigation
Jump to search
scientific article published on 10 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy. |
scientific article published on 10 September 2010 |
Statements
1 reference
Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy (English)
Amr R Ibrahim
Christos Paliompeis
Marco Bua
Dragana Milojkovic
Jamshid S Khorashad
Letizia Foroni
Alistair Reid
Hugues de Lavallade
Katayoun Rezvani
Jane F Apperley
John M Goldman
David Marin
10 September 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference